← Eichor
Study identifier: NCT07451171 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Comparative Efficacy of Antibiotics for Small Intestine Bacterial Overgrowth in Bangladeshi Children

Condition: Small Intestine Bacterial Overgrowth  ·  Sponsor: University of Virginia

PhasePhase 2
Planned participants60
Who can joinAll sexes, 1 Year to 2 Years
Healthy volunteersNo

About this study

The purpose of this Phase IIa study is to identify the most effective antibiotic regimen to treat small intestine bacterial overgrowth (SIBO) in impoverished Bangladeshi children.

This description comes directly from the study's public registry record.

Talk to the study team

Jeffrey R Donowitz, MD  ·  434-243-8824  ·  jrd9d@virginia.edu

Always discuss trial participation with your own doctor first.

Locations (1)

International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)Dhaka, BangladeshRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07451171